What Should Be Chronic: The Animal, the Model, or Both?

The systematic review of mesenchymal stromal cell (MSC) therapy in pulmonary fibrosis by Srour and Thébaud published in a recent issue of Stem Cells Translational Medicine is critically reviewed; Rubio et al. suggest that bleomycin-induced lung injury in aged mice studied over time is a more clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio, Gustavo A., Elliot, Sharon J., Glassberg, Marilyn K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835255/
https://www.ncbi.nlm.nih.gov/pubmed/27091588
http://dx.doi.org/10.5966/sctm.2015-0325
Descripción
Sumario:The systematic review of mesenchymal stromal cell (MSC) therapy in pulmonary fibrosis by Srour and Thébaud published in a recent issue of Stem Cells Translational Medicine is critically reviewed; Rubio et al. suggest that bleomycin-induced lung injury in aged mice studied over time is a more clinically applicable model for human idiopathic pulmonary fibrosis.

Ejemplares similares